CEO pay benchmark · $10B – $200B
Large-cap Pharmaceutical Preparations CEO salary
The median CEO compensation at large-cap companies in the pharmaceutical preparations industry is $15,108,958. That is 17% higher than the median across all pharmaceutical preparations companies in our benchmark.
Median CEO pay
$15.1M
Typical range
$12.2M–$19.2M
Companies
18
Average pay ratio
23:1
Vs. full industry
+17%
Size effect
How this group compares with the full industry
The same compensation measures are shown side by side, so the company-size difference is visible without mixing in another dataset.
| Measure | Large-cap | All Pharmaceutical Preparations |
|---|---|---|
| Companies | 18 | 53 |
| Median CEO pay | $15,108,958 | $12,871,506 |
| Average CEO pay | $15,378,744 | $17,921,011 |
| Middle 50% range | $12.2M–$19.2M | $7.9M–$19.2M |
| Average pay ratio | 23:1 | 122:1 |
Company appendix
Highest CEO pay in this peer group
Up to ten of the highest-paid CEOs in this benchmark, ordered by total annual compensation. Open any company for its full pay breakdown.
| Company | CEO | Total compensation | Market cap |
|---|---|---|---|
| Roivant Sciences Ltd.ROIV | Eric Venker | $24.4M | $25.1B |
| ABBOTT LABORATORIESABT | Robert B. Ford | $24.2M | $198.5B |
| BIOMARIN PHARMACEUTICAL INCBMRN | Alexander Hardy | $21.9M | $11.4B |
| VERTEX PHARMACEUTICALS INC / MAVRTX | Reshma Kewalramani | $21.1M | $134.1B |
| MADRIGAL PHARMACEUTICALS, INC.MDGL | Bill Sibold | $19.2M | $12.0B |
| TEVA PHARMACEUTICAL INDUSTRIES LTDTEVA | Richard Francis | $19.2M | $39.8B |
| Jazz Pharmaceuticals plcJAZZ | Renee D. Gala | $19.2M | $14.8B |
| CORCEPT THERAPEUTICS INCCORT | Joseph K. Belanoff | $15.3M | $12.9B |
| Viatris IncVTRS | Scott A. Smith | $15.3M | $18.8B |
| BridgeBio Pharma, Inc.BBIO | Neil Kumar | $14.9M | $15.5B |
Nearby peer groups